<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/069AABE7-ED6F-470F-9A25-F547706D30E3"><gtr:id>069AABE7-ED6F-470F-9A25-F547706D30E3</gtr:id><gtr:name>University of Sri Jayewardenepura</gtr:name><gtr:address><gtr:line1>Gangodawila</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/069AABE7-ED6F-470F-9A25-F547706D30E3"><gtr:id>069AABE7-ED6F-470F-9A25-F547706D30E3</gtr:id><gtr:name>University of Sri Jayewardenepura</gtr:name><gtr:address><gtr:line1>Gangodawila</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C2464840-7606-47D9-AE5C-D1A6A69906BC"><gtr:id>C2464840-7606-47D9-AE5C-D1A6A69906BC</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:surname>Ogg</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G116%2F150"><gtr:id>86D4C225-9288-489D-A02A-0C69510E5B7A</gtr:id><gtr:title>Characterisation of the role of T cells in the pathogeesis of atopic dermatitis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G116/150</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1009703</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>Biomedical Research centre Oxford</gtr:description><gtr:id>E261E826-C241-43C2-BBF0-74AAFF816B36</gtr:id><gtr:impact>Many outputs as detailed in relevant sections</gtr:impact><gtr:outcomeId>9AA2B554C0F-1</gtr:outcomeId><gtr:partnerContribution>Access to equipment and individuals</gtr:partnerContribution><gtr:piContribution>We provided many of the samples and technology for analysis of samples using Biomedical Research Centre equipment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Transduction of TCR</gtr:description><gtr:id>662DC13C-9952-4C50-A524-A285B9B89CA8</gtr:id><gtr:impact>Still early stages</gtr:impact><gtr:outcomeId>JaBRcgvhrDU-1</gtr:outcomeId><gtr:partnerContribution>Help with cloning TCR into primary T cells</gtr:partnerContribution><gtr:piContribution>Provision of T cell clones</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Molecular Haematology Unit</gtr:department><gtr:description>Paul Klenerman VZV</gtr:description><gtr:id>9B10CAB3-9871-4DEF-A971-D91D5280EEAD</gtr:id><gtr:impact>Publications and presentations</gtr:impact><gtr:outcomeId>n58mg5xYF4j-1</gtr:outcomeId><gtr:partnerContribution>Access to samples and discussions.</gtr:partnerContribution><gtr:piContribution>Analysis of varicella zoster virus specific immune respoonses after vaccination</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sri Jayawardanapura</gtr:collaboratingOrganisation><gtr:country>Sri Lanka, Democratic Socialist Republic of</gtr:country><gtr:description>University of Sri Jayawardanapura</gtr:description><gtr:id>7ABE64B8-9D8D-4C8E-851E-3D9B233949AA</gtr:id><gtr:impact>see relevant sections</gtr:impact><gtr:outcomeId>22B631EF49D-1</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and some analyses</gtr:partnerContribution><gtr:piContribution>Analyses of samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Medical Molecular Virology</gtr:department><gtr:description>Judy Breuer</gtr:description><gtr:id>CE95FC74-B346-4231-89AD-8EB3C02A80EE</gtr:id><gtr:impact>see relevant sections</gtr:impact><gtr:outcomeId>777CE819968-1</gtr:outcomeId><gtr:partnerContribution>Provision of samples and analyses</gtr:partnerContribution><gtr:piContribution>Analyses of T cell responses to varicella zoster virus</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>National Science Week</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EDC67109-8DF6-40ED-B0F5-0D32869E417B</gtr:id><gtr:impact>Approximately 150 members of public attended lectures and displays

I have many school children who wish to have lab attachments</gtr:impact><gtr:outcomeId>PxUtfTLkmhV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>Janssen Pharmaceuticals</gtr:department><gtr:description>Janssen collaborative research grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Johnson &amp; Johnson</gtr:fundingOrg><gtr:id>7494CBFA-0A40-4A62-A321-63428B6026DB</gtr:id><gtr:outcomeId>e6E7e5rRAQR</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Medical Association</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>British Medical Association (BMA)</gtr:fundingOrg><gtr:id>8EE26A26-913F-453C-87C9-E1224FC7B07A</gtr:id><gtr:outcomeId>hpdkGoswfpr0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>380000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Experimental Medicine 2</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5DD251B0-A48E-4990-91B9-9657E72E5FE2</gtr:id><gtr:outcomeId>A5760EEF7EE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>We observed that staphylococcal superantigen facilitates antigen presentation of allergen by epithelial cells. This potentially explains a clinical observation seen in individuals with atopic dermatitis, that flares of disease are often associated with infection. The underlying mechanisms were characterised. I believe this is important for understanding of disease and for the development of new treatment approaches (recent award of MRC Experimental Medicine 2 funding to take this into a proof-of-principle clinical trial).</gtr:description><gtr:id>90D2CB61-D891-4304-82EA-60BE933BE7FA</gtr:id><gtr:impact>We hope that this will provide patient benefit</gtr:impact><gtr:outcomeId>963A8CDB66F</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Idea that combined allergen and anti-bacterial approaches may benefit patients with atopic disease</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2007</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I was involved in the later stages of HLA peptide tetrameric complex development and refinement of their use (first developed by John Altman, Mark Davis, Andrew McMichael, John Bell et al) and their application to the study of human disease</gtr:description><gtr:id>83C12D17-7A12-4D3E-B652-426348A5344B</gtr:id><gtr:impact>Vast number of publications have now used the technology</gtr:impact><gtr:outcomeId>F4C4A7A7752</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HLA peptide tetrameric complexes</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Allergen-specific T cells were derived from human peripheral blood and used to show an interaction with S.aureus. This has lead to the award of an MRC Experimental Medicine 2 grant for a proof of concept clinical trial.</gtr:description><gtr:id>D3F8A324-3A19-4104-8491-03556BD8E6F6</gtr:id><gtr:impact>many outputs - see relevant sections</gtr:impact><gtr:outcomeId>7D41E1E1024</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Allergen-specific T cells</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>804D60BA-DA11-491B-98FA-F6797418F64E</gtr:id><gtr:title>Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e33acbcfebc59f56dcd3f5a93527f83"><gtr:id>2e33acbcfebc59f56dcd3f5a93527f83</gtr:id><gtr:otherNames>Stebbing J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13469_19_14604955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDEBC036-0AE0-4397-8404-D95A3361BE96</gtr:id><gtr:title>T-cell immunotherapy of allergic disease: the role of CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e232cef9eb0f7b8195fb3a6a6a5d263"><gtr:id>9e232cef9eb0f7b8195fb3a6a6a5d263</gtr:id><gtr:otherNames>Ogg GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1473-6322</gtr:issn><gtr:outcomeId>pm_13469_19_14612672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE0CCB19-3B2C-4268-AB6E-D6DAD3CE04D3</gtr:id><gtr:title>Rapid effector function of circulating NC16A-specific T cells in individuals with mucous membrane pemphigoid.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>pm_13469_19_15606510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1CAA40B-8295-4CC8-9F4F-E39FE656EF9B</gtr:id><gtr:title>Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eea9935cd8f2c61959e13fbef7e6296b"><gtr:id>eea9935cd8f2c61959e13fbef7e6296b</gtr:id><gtr:otherNames>Savage P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13469_19_14988155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2B18E9E-DC22-4479-AA61-AD10E3126DBC</gtr:id><gtr:title>Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5A5CCB8D2BF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B366A55-39A7-4B75-A740-3A218712CC8C</gtr:id><gtr:title>Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/538bc1c1d0dce3abd60b92ee5659ff0b"><gtr:id>538bc1c1d0dce3abd60b92ee5659ff0b</gtr:id><gtr:otherNames>Bateman EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>BBBA6BB4AAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CF53544-5A50-4696-8548-95432A9E25A7</gtr:id><gtr:title>Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivo.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e33acbcfebc59f56dcd3f5a93527f83"><gtr:id>2e33acbcfebc59f56dcd3f5a93527f83</gtr:id><gtr:otherNames>Stebbing J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_13469_19_15577637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E35E138-638B-439D-9D1E-9839C994A030</gtr:id><gtr:title>Immune evasion during varicella zoster virus infection of keratinocytes.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>41DA881E88D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A3D7D76-1353-4090-BABC-EED538060859</gtr:id><gtr:title>Interleukin-4 promotes human CD8 T cell expression of CCR7.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40aa42fee4e0a19f2c78207a21b0d3d4"><gtr:id>40aa42fee4e0a19f2c78207a21b0d3d4</gtr:id><gtr:otherNames>Seneviratne SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>CFBC3F1CBC4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDD0243E-5DD7-4D4B-A9EA-E0749C7A2000</gtr:id><gtr:title>Immunotherapy with antibody-targeted HLA class I complexes: results of in vivo tumour cell killing and therapeutic vaccination.</gtr:title><gtr:parentPublicationTitle>Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eea9935cd8f2c61959e13fbef7e6296b"><gtr:id>eea9935cd8f2c61959e13fbef7e6296b</gtr:id><gtr:otherNames>Savage P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1010-4283</gtr:issn><gtr:outcomeId>DA937CAC849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDCD11E1-E586-4542-A828-0EF7CE9C7CB8</gtr:id><gtr:title>Interleukin-4 induced down-regulation of skin homing receptor expression by human viral-specific CD8 T cells may contribute to atopic risk of cutaneous infection.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40aa42fee4e0a19f2c78207a21b0d3d4"><gtr:id>40aa42fee4e0a19f2c78207a21b0d3d4</gtr:id><gtr:otherNames>Seneviratne SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>pm_13469_19_15958076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>279DB013-972D-4FE7-98FF-0ED48E87B09D</gtr:id><gtr:title>Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2abd7ea4a2d38b6996263dc56bf14550"><gtr:id>2abd7ea4a2d38b6996263dc56bf14550</gtr:id><gtr:otherNames>Salimi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56c826ce21b895.27592657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B47A614-659E-4B16-9CF9-3176E7894CF2</gtr:id><gtr:title>HLA analysis of Sri Lankan Sinhalese predicts North Indian origin.</gtr:title><gtr:parentPublicationTitle>International journal of immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-3121</gtr:issn><gtr:outcomeId>2C017CB0832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F24BA68-EAED-4D9A-AEFE-3F8C1A4C47F3</gtr:id><gtr:title>p53-specific CD8+ T-cell responses in individuals with cutaneous squamous cell carcinoma.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>pm_13469_19_16225611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0CD045B-E387-465A-850E-86901A889F6E</gtr:id><gtr:title>Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>E6EC0B73B35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>948F5646-EABA-47F3-9C96-73B1871CA4ED</gtr:id><gtr:title>Severe atopic dermatitis is associated with a reduced frequency of IL-10 producing allergen-specific CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40aa42fee4e0a19f2c78207a21b0d3d4"><gtr:id>40aa42fee4e0a19f2c78207a21b0d3d4</gtr:id><gtr:otherNames>Seneviratne SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>B4A23F9AD23</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BBA91C6-83A5-4E68-9AFF-F096E138F4C9</gtr:id><gtr:title>ELISPOT and functional T cell analyses using HLA mono-specific target cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a19b519761d8526dc0248cb3024018"><gtr:id>e1a19b519761d8526dc0248cb3024018</gtr:id><gtr:otherNames>Horlock C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>B5EBE9457F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E6AC423-E0B7-4670-9745-26B47EA4D247</gtr:id><gtr:title>Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42879182b70aef11f7c113122fc89efd"><gtr:id>42879182b70aef11f7c113122fc89efd</gtr:id><gtr:otherNames>Ardern-Jones MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>887E21210A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99C4FA1E-B650-4DA7-9D59-826C193E38C2</gtr:id><gtr:title>Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13469_19_16973581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B51F281B-21D1-4EF6-94F8-2473BB9887FD</gtr:id><gtr:title>Defining the T cell antigen proteome of wasp venom.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31d0e3a7e251ddfd1290bf38f51937a3"><gtr:id>31d0e3a7e251ddfd1290bf38f51937a3</gtr:id><gtr:otherNames>Aslam A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>B70FE8697E2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5CC93BC-EECE-44B6-A15D-BEF292F0BC76</gtr:id><gtr:title>Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>DCF01B147CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF5684D5-0381-487E-A47E-BCE0B7213397</gtr:id><gtr:title>Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>58EB5DAD7E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA068085-5605-4B2A-87B5-8E76A3B9184D</gtr:id><gtr:title>Identification of an immunodominant region of Fel d 1 and characterization of constituent epitopes.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/538bc1c1d0dce3abd60b92ee5659ff0b"><gtr:id>538bc1c1d0dce3abd60b92ee5659ff0b</gtr:id><gtr:otherNames>Bateman EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>9F2952059A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABA6CC2F-E608-42FF-9A0D-42A902FB8706</gtr:id><gtr:title>The role of p53 in the immunobiology of cutaneous squamous cell carcinoma.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>pm_13469_19_12780682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2C4459C-E501-45A1-AC59-C16CF94EFB6F</gtr:id><gtr:title>A novel fluorescent sensitive assay for detection of differential T cell mediated lysis of multiple adherent target cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>6D51318B609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C164D8B-1742-41CE-9D83-51A1E13B9FAC</gtr:id><gtr:title>Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/538bc1c1d0dce3abd60b92ee5659ff0b"><gtr:id>538bc1c1d0dce3abd60b92ee5659ff0b</gtr:id><gtr:otherNames>Bateman EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>D1BBFBF7E50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6177F528-39EF-4649-8DCC-63A6F4721667</gtr:id><gtr:title>Tracking epitope-specific antiviral CD4+ T cell responses to a live attenuated vaccine reveals ongoing functional responses.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>A2EA415E9C3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA02FB9C-085B-4A6C-861F-55EBC11DACA5</gtr:id><gtr:title>The role of skin-homing T cells in extrinsic atopic dermatitis.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40aa42fee4e0a19f2c78207a21b0d3d4"><gtr:id>40aa42fee4e0a19f2c78207a21b0d3d4</gtr:id><gtr:otherNames>Seneviratne SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>E7725DEA57D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCCC4794-68EF-4E1F-8CFB-18DB485F805E</gtr:id><gtr:title>CD4(-)CD8alphaalpha subset of CD1d-restricted NKT cells controls T cell expansion.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3744dbe1aa8c3b72c3e4f82972a51aaa"><gtr:id>3744dbe1aa8c3b72c3e4f82972a51aaa</gtr:id><gtr:otherNames>Ho LP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_13469_19_15187111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19F56AB8-2096-4B19-8087-19F8D9310F9B</gtr:id><gtr:title>Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.</gtr:title><gtr:parentPublicationTitle>Laboratory investigation; a journal of technical methods and pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43c4368869b3985c025a430e6d147634"><gtr:id>43c4368869b3985c025a430e6d147634</gtr:id><gtr:otherNames>Wankowicz-Kalinska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0023-6837</gtr:issn><gtr:outcomeId>pm_13469_19_12746478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>299393E2-79C6-4D18-B89C-802F320DE885</gtr:id><gtr:title>Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6be22181e65319312bcaf4fe79256e1f"><gtr:id>6be22181e65319312bcaf4fe79256e1f</gtr:id><gtr:otherNames>Webster GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13469_19_15140968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5486F2E7-FCB6-4B7F-AB85-6A4EB6092ADF</gtr:id><gtr:title>TLR2 is expressed on activated T cells as a costimulatory receptor.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13469_19_14981245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29B3ADBB-4B34-4820-9C3A-F8213D43653E</gtr:id><gtr:title>Role of T cells in the pathogenesis of atopic dermatitis.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d025a8be1ad9503cf6a700aa3f87ed7"><gtr:id>6d025a8be1ad9503cf6a700aa3f87ed7</gtr:id><gtr:otherNames>Ogg G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>BFC15665FB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0090BDE7-2457-4FAE-9C31-B2231CE1702C</gtr:id><gtr:title>Anti-lymphocyte function associated antigen-1 inhibits T-helper 2 function of human allergen-specific CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42879182b70aef11f7c113122fc89efd"><gtr:id>42879182b70aef11f7c113122fc89efd</gtr:id><gtr:otherNames>Ardern-Jones MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>3C3EA698E53</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EFDCBD3-C53B-4848-90FF-9E1A6DF08E65</gtr:id><gtr:title>Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>DD675A3C589</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G116/150</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>7EE9741E-CF94-420A-B0AB-A7811523CF2C</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Skin</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>